A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
Status:
NOT_YET_RECRUITING
Trial end date:
2030-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).